Contact Careers rss

AIDS Vaccine Conference 2010 Logo The Global HIV Vaccine Enterprise (the Enterprise) is a unique alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine. The Enterprise will put forward a Scientific Strategic Plan for HIV vaccine research and development in 2010. Five working groups involving more than 100 scientists from around the world have been convened under the Enterprise to put forward recommendations for investment of finances and resources to further the field and the Enterprise's mission. These recommendations will comprise the 2010 Scientific Strategic Plan.

Working Group 1 - Immunogens and Antigen Processing Working Group 2 - Host Genetics and HIV Diversity Working Group 3 - Novel Approaches to HIV Vaccine Research and Development Working Group 4 - Bridging The Gaps Working Group 5 - Young & Early Career Investigators (YECI)
In the February 2005 issue of Public Library of Science (PLoS) - Medicine, the Enterprise published a scientific strategic plan for accelerating HIV vaccine research. The Plan described the major challenges facing the field at that time and made recommendations in six priority areas: History of the Plan
  • Vaccine discovery
  • Laboratory standardization
  • Product development & manufacturing
  • Clinical trials capacity
  • Intellectual property issues
  • Regulatory considerations
The 2005 Plan catalyzed major, new activities and funding commitments of a number of government and non-government organizations. It also led to the creation of new research structures and new ways of collaborating on a global scale.

Learn More..

The Enterprise is a unique alliance of organizations that has the convening power to bring together an inclusive global alliance of top researchers, funders, advocacy groups, and stakeholders to catalyze fresh thinking, set new directions and advance global cooperation to develop an HIV vaccine.
Global HIV Vaccine Enterprise, 200 Park Ave. S. Suite 1501, New York, NY 10003 | +1 212-461-3692 or toll free at +1-866-966-4483

All Content ©2005 - 2010 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account